Your browser doesn't support javascript.
loading
Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming.
Adeshakin, Funmilayo O; Adeshakin, Adeleye O; Afolabi, Lukman O; Yan, Dehong; Zhang, Guizhong; Wan, Xiaochun.
Afiliação
  • Adeshakin FO; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
  • Adeshakin AO; University of Chinese Academy of Sciences, Beijing, China.
  • Afolabi LO; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
  • Yan D; University of Chinese Academy of Sciences, Beijing, China.
  • Zhang G; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
  • Wan X; University of Chinese Academy of Sciences, Beijing, China.
Front Oncol ; 11: 626577, 2021.
Article em En | MEDLINE | ID: mdl-33854965

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article